Literature DB >> 9751335

Malone antegrade continence enema for adults with neurogenic bowel disease.

J M Teichman1, J M Harris, D M Currie, D B Barber.   

Abstract

PURPOSE: We describe the outcomes of adults with neurogenic bowel disease who underwent a Malone antegrade continence enema procedure with or without concomitant urinary diversion.
MATERIALS AND METHODS: Consecutive adult patients with neurogenic bowel disease who underwent an antegrade continence enema procedure (continent catheterizable appendicocecostomy for fecal impaction) were retrospectively reviewed.
RESULTS: Of the 7 patients who underwent an antegrade continence enema synchronous urinary procedure (ileal conduit, augmentation ileocystoplasty with continent catheterizable abdominal stoma or augmentation ileocystoplasty) was also performed in 6. Mean patient age was 32 years and mean followup was 11 months. Of the 7 patients 6 who self-administered antegrade continence enemas regularly were continent of stool per rectum and appendicocecostomy, using the appendicocecostomy as the portal for antegrade enemas. All 6 compliant patients reported decreased toileting time and improved quality of life. Preoperative autonomic dysreflexia resolved postoperatively in 3 patients. All urinary tracts were stable. In 4 patients 5 complications occurred, including antegrade continence enema stomal stenosis requiring appendicocutaneous revision (1), antegrade continence enema stomal stenosis requiring dilation (1), superficial wound infection (1), small bowel obstruction requiring lysis of adhesions (1) and urinary incontinence (1 who underwent continent urinary diversion).
CONCLUSIONS: Patients with neurogenic bladder and bowel disease may benefit from antegrade continence enema performed synchronously with a urinary procedure. Antegrade continence enema may be indicated alone for neurogenic bowel. Patient selection is important.

Entities:  

Mesh:

Year:  1998        PMID: 9751335

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Authors:  Julie Ann M Van Koughnett; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Variation in surgical management of neurogenic bowel among centers participating in National Spina Bifida Patient Registry.

Authors:  Jonathan C Routh; David B Joseph; Tiebin Liu; Michael S Schechter; Judy K Thibadeau; M Chad Wallis; Elisabeth A Ward; John S Wiener
Journal:  J Pediatr Rehabil Med       Date:  2017-12-11

Review 3.  Neurogenic bowel management after spinal cord injury: a systematic review of the evidence.

Authors:  A Krassioukov; J J Eng; G Claxton; B M Sakakibara; S Shum
Journal:  Spinal Cord       Date:  2010-03-09       Impact factor: 2.772

4.  Prevention of recurrent autonomic dysreflexia: a survey of current practice.

Authors:  Deborah Caruso; David Gater; Christopher Harnish
Journal:  Clin Auton Res       Date:  2015-08-18       Impact factor: 4.435

5.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Mark Korsten
Journal:  J Spinal Cord Med       Date:  2021-05       Impact factor: 1.985

6.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Catherine Wilson; Mark Korsten
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.